Patents by Inventor Qiting WU

Qiting WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12617828
    Abstract: Provided are a genetically modified immune cell, a preparation method therefor, and an application. The immune cell overexpresses HIL-6 and/or L-GP130. HIL-6 or L-GP130 continuous overexpression/conditionally induced overexpression in the immune cell reduces the side effects of CAR-T therapy while maintaining immune and anti-tumour effects, and has potential value in the treatment of malignant tumours and AIDS.
    Type: Grant
    Filed: May 6, 2020
    Date of Patent: May 5, 2026
    Assignee: SHENZHEN IN VIVO BIOMEDICINE TECHNOLOGY LIMITED COMPANY
    Inventors: Peng Li, Zhiwu Jiang, Zhaoyang Tang, Rui Liao, Xiaohan Huang, Simiao Lin, Suna Wang, Youguo Long, Qiting Wu, Yao Yao
  • Publication number: 20220185858
    Abstract: Provided are a genetically modified immune cell, a preparation method therefor, and an application. The immune cell overexpresses HIL-6 and/or L-GP130. HIL-6 or L-GP130 continuous overexpression/conditionally induced overexpression in the immune cell reduces the side effects of CAR-T therapy while maintaining immune and anti-tumour effects, and has potential value in the treatment of malignant tumours and AIDS.
    Type: Application
    Filed: May 6, 2020
    Publication date: June 16, 2022
    Applicant: SHENZHEN IN VIVO BIOMEDICINE TECHNOLOGY LIMITED COMPANY
    Inventors: Peng LI, Zhiwu JIANG, Zhaoyang TANG, Rui LIAO, Xiaohan HUANG, Simiao LIN, Suna WANG, Youguo LONG, Qiting WU, Yao YAO
  • Patent number: D1095164
    Type: Grant
    Filed: January 18, 2024
    Date of Patent: September 30, 2025
    Assignee: Shenzhen Qiqile Trading Co., Ltd.
    Inventors: Qiting Wu, Liwei Peng, Liyao Peng